Thymosin Alpha-1

Thymosin alpha-1 (Tα1) is a 28-amino acid peptide originally isolated from the thymus gland. It is a naturally occurring peptide that plays a central role in T-cell maturation and immune regulation. As the thymus involutes with age — losing function from the mid-20s onward — Tα1 levels decline, correlating with the immunosenescence seen in aging.

Synthetic thymosin alpha-1 (brand: Zadaxin) is approved in over 37 countries for hepatitis B, hepatitis C, and malignant melanoma. Rather than broadly stimulating the immune system, it works through specific immunological pathways:

• T-cell differentiation: promotes maturation of T-cell precursors in the thymus and periphery
• NK cell activation: enhances natural killer cell activity and cytotoxicity
• Dendritic cell function: improves antigen presentation and adaptive immune initiation
• Cytokine regulation: modulates pro-inflammatory and anti-inflammatory cytokine balance
• Regulatory T-cells: evidence for Treg modulation, relevant for autoimmune applications

Thymosin alpha-1 has an excellent safety profile — it is a naturally occurring peptide that the body already produces. The most common side effects:

• Mild injection site reactions (redness, swelling)
• Rare systemic reactions have been reported

In patients with active autoimmune conditions, careful monitoring is appropriate, as immune modulation can have unpredictable effects on autoimmune disease activity. Discuss any autoimmune history with your physician before starting.